Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥65.40 Million ≈ $9.57 Million USD) by net assets (CN¥2.38 Billion ≈ $347.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jiangxi Synergy Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300636 liabilities breakdown for a breakdown of total debt and financial obligations.

Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LASSONDE INDUST.INC. A F:0OO	N/A
Nanjing Toua Hardware&Tools Co.Ltd. SHE:301125	0.032x
SKS Technologies Group Ltd AU:SKS	0.652x
Hubei Guochuang Hi-tech Material Co Ltd SHE:002377	-0.083x
Faraday Copper Corp. TO:FDY	-0.055x
John Mattson Fastighetsforetagen AB ST:JOMA	0.008x
SA Corporate Real Estate Fund Managers Ltd JSE:SAC	0.023x
Tejon Ranch Co NYSE:TRC	-0.005x

Annual Cash Flow Conversion Efficiency for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300636 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.31 Billion ≈ $337.84 Million	CN¥285.19 Million ≈ $41.73 Million	0.124x	+67.95%
2023-12-31	CN¥2.23 Billion ≈ $325.80 Million	CN¥163.75 Million ≈ $23.96 Million	0.074x	-50.48%
2022-12-31	CN¥1.32 Billion ≈ $193.11 Million	CN¥196.00 Million ≈ $28.68 Million	0.149x	+0.43%
2021-12-31	CN¥888.11 Million ≈ $129.96 Million	CN¥131.34 Million ≈ $19.22 Million	0.148x	+50.81%
2020-12-31	CN¥816.50 Million ≈ $119.48 Million	CN¥80.07 Million ≈ $11.72 Million	0.098x	+344.98%
2019-12-31	CN¥706.31 Million ≈ $103.36 Million	CN¥-28.27 Million ≈ $-4.14 Million	-0.040x	-135.16%
2018-12-31	CN¥658.16 Million ≈ $96.31 Million	CN¥74.93 Million ≈ $10.96 Million	0.114x	+113.00%
2017-12-31	CN¥637.10 Million ≈ $93.23 Million	CN¥34.05 Million ≈ $4.98 Million	0.053x	-73.06%
2016-12-31	CN¥304.66 Million ≈ $44.58 Million	CN¥60.45 Million ≈ $8.85 Million	0.198x	-38.38%
2015-12-31	CN¥246.66 Million ≈ $36.09 Million	CN¥79.42 Million ≈ $11.62 Million	0.322x	-41.08%
2014-12-31	CN¥118.02 Million ≈ $17.27 Million	CN¥64.50 Million ≈ $9.44 Million	0.547x	+198.77%
2013-12-31	CN¥78.82 Million ≈ $11.53 Million	CN¥14.42 Million ≈ $2.11 Million	0.183x	+406.36%
2012-12-31	CN¥45.51 Million ≈ $6.66 Million	CN¥-2.72 Million ≈ $-397.62K	-0.060x	--

About Jiangxi Synergy Pharmaceutical Co Ltd

SHE:300636 China Drug Manufacturers - Specialty & Generic

Market Cap

$480.56 Million

CN¥3.28 Billion CNY

Market Cap Rank

#12738 Global

#3982 in China

Share Price

CN¥7.82

Change (1 day)

+0.64%

52-Week Range

CN¥7.22 - CN¥9.30

All Time High

CN¥15532.43